Henry Ford Health ST. John Hospital

Henry Ford Health ST. John Hospital was paid $159.41M by Medicaid between Jan 2018 and Dec 2024, across 752 billing codes. Its largest line is 99285, emergency room visit (most serious) — 16% of everything it billed.

33Billing provider infoHENRY FORD HEALTH ST. JOHN HOSPITAL
CHICAGO, IL 60677

33aNPI1023088168assigned 01/23/2006

33bProvider typeAmbulatory Surgical Clinic/Center

28Total paid$159.41M

24GClaims6,873,326

24DCodes billed752

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Illinois

Rank by total paid#1 of 29

Median peer was paid$1K

This provider vs. median110,430×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	642,447	$19.68M
2019	1,186,445	$21.89M
2020	1,028,497	$20.94M
2021	1,278,936	$26.46M
2022	1,305,488	$28.92M
2023	993,921	$25.42M
2024incomplete	437,592	$16.09M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	16%	60,872	56,631	$25.19M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	8.7%	81,360	76,637	$13.89M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	8.6%	102,906	97,523	$13.74M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	7.2%	215,313	192,819	$11.42M
G0378	Hospital observation service, per hour	5.2%	28,350	24,184	$8.25M
J9271	Injection, pembrolizumab, 1 mg	3.1%	861	688	$4.88M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	2.5%	52,494	48,415	$3.95M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.7%	29,193	27,641	$2.78M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.6%	140,635	136,571	$2.49M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.6%	141,171	136,961	$2.48M
80061	Lipid panel	1.4%	196,633	193,751	$2.25M
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	1.4%	133,971	131,956	$2.24M

740 more codes

96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	13,117	$2.14M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	1.2%	3,529	$1.93M
84443	Thyroid stimulating hormone (TSH)	1.2%	198,677	$1.93M
99281	Emergency department visit for the evaluation and management, self-limited or minor	1.0%	25,553	$1.64M
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	100,077	$1.56M
80053	Comprehensive metabolic panel	<1%	259,862	$1.40M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	14,648	$1.36M
71046	Radiologic examination, chest; 2 views	<1%	38,053	$1.22M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	22,085	$1.22M
96361	Intravenous infusion, hydration; each additional hour	<1%	33,143	$1.20M
82947		<1%	63,022	$1.18M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	384,322	$1.17M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	12,428	$1.14M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,737	$997K
93975		<1%	9,982	$971K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	44,064	$948K
70450	Computed tomography, head or brain; without contrast material	<1%	13,330	$947K
87390		<1%	70,693	$937K
83036	Hemoglobin; glycosylated (A1C)	<1%	166,416	$931K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	15,691	$896K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	6,848	$817K
96375	Therapeutic injection; each additional sequential IV push	<1%	30,976	$804K
93458		<1%	520	$778K
59025	Fetal non-stress test	<1%	8,413	$764K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	8,864	$758K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	14,120	$701K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,895	$698K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,931	$693K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	26,563	$655K
81514		<1%	3,647	$616K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	13,473	$608K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	22,077	$567K
86702		<1%	71,221	$543K
80074		<1%	20,124	$541K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	178	$518K
82607		<1%	57,079	$508K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	23,608	$501K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	43,967	$487K
86003		<1%	4,827	$470K
86803		<1%	54,405	$463K
86780		<1%	54,070	$461K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	21,848	$456K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	23,520	$450K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,195	$444K
J0897	Injection, denosumab, 1 mg	<1%	402	$407K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	28,671	$406K
76801		<1%	8,358	$406K
76830	Ultrasound, transvaginal	<1%	7,068	$367K
87086	Culture, bacterial; quantitative colony count, urine	<1%	88,927	$365K
86701		<1%	71,073	$357K
84439		<1%	65,799	$349K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	7,763	$346K
71045	Radiologic examination, chest; single view	<1%	12,253	$330K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,801	$320K
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	411	$318K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,219	$307K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	733	$302K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,154	$301K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,568	$301K
82728		<1%	35,859	$287K
78815	Positron emission tomography (PET) for limited area imaging	<1%	356	$276K
31579		<1%	1,330	$269K
86900		<1%	32,755	$259K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	9,262	$250K
84702		<1%	39,342	$246K
96416		<1%	1,419	$237K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	9,863	$234K
80048	Basic metabolic panel (calcium, ionized)	<1%	125,848	$229K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	14,513	$221K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	8,039	$220K
90677		<1%	2,265	$219K
96367		<1%	5,246	$213K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	18,465	$207K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	2,503	$205K
83550		<1%	39,831	$204K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	722	$203K
83735		<1%	65,406	$194K
90670		<1%	11,692	$194K
87340		<1%	33,513	$190K
90651		<1%	3,488	$185K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	2,891	$176K
31231		<1%	2,071	$174K
76642		<1%	4,546	$172K
96415		<1%	4,043	$172K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,233	$168K
77063	Screening digital breast tomosynthesis, bilateral	<1%	12,486	$167K
36415	Collection of venous blood by venipuncture	<1%	303,320	$165K
83970		<1%	7,014	$163K
83540		<1%	42,246	$162K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	12,997	$159K
86769		<1%	6,449	$158K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	3,900	$156K
96417		<1%	3,992	$152K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,810	$152K
97161		<1%	2,767	$150K
85027		<1%	57,561	$147K
76770		<1%	3,072	$143K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	4,963	$143K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	9,679	$141K
31575		<1%	1,813	$140K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,844	$136K
76536		<1%	2,696	$135K
J2505	Injection, pegfilgrastim, 6 mg	<1%	116	$135K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	5,275	$132K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,504	$132K
93970		<1%	1,539	$131K
58558		<1%	92	$129K
87070		<1%	27,668	$129K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	5,576	$127K
10060		<1%	1,765	$126K
90472	Immunization administration, each additional vaccine (list separately)	<1%	7,720	$125K
82570		<1%	40,995	$122K
84146		<1%	10,379	$121K
97162		<1%	2,274	$119K
83001		<1%	10,290	$116K
93971		<1%	2,743	$115K
81001		<1%	124,197	$115K
82043		<1%	33,082	$114K
82746		<1%	13,365	$113K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	637	$112K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	239	$110K
84403		<1%	7,454	$110K
J9035	Injection, bevacizumab, 10 mg	<1%	65	$109K
82670		<1%	6,410	$109K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,850	$108K
86696		<1%	9,980	$107K
86762		<1%	13,300	$107K
87529		<1%	3,813	$106K
A9270	Non-covered item or service	<1%	112,442	$105K
87536		<1%	2,200	$104K
19083		<1%	133	$104K
93304		<1%	406	$104K
70496		<1%	1,476	$101K
72141		<1%	914	$101K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,963	$101K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	13,261	$100K
93976		<1%	2,424	$100K
20610		<1%	620	$100K
84480		<1%	11,415	$98K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	4,448	$96K
87088		<1%	23,771	$96K
83002		<1%	8,541	$96K
86038		<1%	13,594	$95K
90686		<1%	12,294	$92K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	197	$91K
84550		<1%	38,201	$90K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,171	$86K
70491		<1%	930	$84K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	4,923	$82K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	56,112	$80K
87077		<1%	18,542	$80K
82550		<1%	22,490	$79K
87186		<1%	17,807	$78K
84484		<1%	31,341	$77K
Q3014	Telehealth originating site facility fee	<1%	4,437	$77K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,740	$75K
83880		<1%	7,489	$73K
86850		<1%	32,949	$73K
86706		<1%	12,848	$73K
83690		<1%	35,087	$72K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	437	$71K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	531	$69K
90732		<1%	671	$68K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	705	$68K
77065	Tomosynthesis, mammo	<1%	1,487	$68K
77066	Tomosynthesis, mammo	<1%	1,138	$67K
86235		<1%	3,107	$66K
99385		<1%	2,516	$66K
83013		<1%	1,433	$66K
84481		<1%	6,742	$65K
J9299	Injection, nivolumab, 1 mg	<1%	15	$63K
82784		<1%	6,077	$63K
84144		<1%	4,858	$62K
86695		<1%	8,523	$62K
70486		<1%	3,465	$62K
84402		<1%	4,236	$61K
95819		<1%	858	$60K
41899	Unlisted procedure, dentoalveolar structures	<1%	27	$60K
83615		<1%	20,856	$58K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	397	$57K
86480		<1%	1,591	$56K
86140		<1%	22,209	$56K
84450		<1%	23,684	$54K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	3,346	$54K
93017		<1%	1,725	$54K
82105		<1%	6,310	$53K
84460		<1%	22,696	$53K
82627		<1%	3,786	$53K
73562		<1%	6,924	$52K
72100		<1%	4,347	$51K
Q5116	Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg	<1%	38	$51K
J9202	Goserelin acetate implant, per 3.6 mg	<1%	494	$51K
97165		<1%	1,593	$50K
82565		<1%	25,679	$50K
83020		<1%	7,035	$49K
G0328	Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous	<1%	4,622	$49K
87081		<1%	13,838	$49K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	89	$48K
96523		<1%	1,583	$47K
96411		<1%	1,232	$47K
87522	Neg quan hep c or qual rna	<1%	1,961	$46K
84100		<1%	22,525	$46K
99386		<1%	1,551	$43K
72125	Computed tomography, cervical spine; without contrast material	<1%	7,415	$43K
96402		<1%	1,909	$43K
90715		<1%	10,762	$43K
73630		<1%	8,235	$42K
Q5126	Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg	<1%	27	$42K
88342		<1%	1,850	$41K
97116		<1%	3,140	$41K
82150		<1%	16,749	$41K
86147		<1%	1,588	$40K
99496		<1%	638	$40K
85610		<1%	39,841	$40K
90674		<1%	1,416	$39K
J1750	Injection, iron dextran, 50 mg	<1%	309	$39K
82747		<1%	3,951	$39K
71271		<1%	695	$39K
Q0091	Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory	<1%	3,385	$39K
82785		<1%	4,090	$39K
86704		<1%	5,582	$38K
86361		<1%	2,761	$37K
81003		<1%	32,931	$37K
96160		<1%	3,296	$37K
83516		<1%	3,329	$37K
80076		<1%	22,150	$37K
85651		<1%	17,219	$36K
Q5122	Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg	<1%	21	$36K
93351		<1%	241	$36K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	19	$36K
88307		<1%	633	$36K
86334		<1%	2,814	$35K
71250		<1%	642	$35K
86376		<1%	4,040	$35K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	10,591	$35K
86225		<1%	4,408	$34K
86870		<1%	761	$34K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	1,721	$34K
G0475	Hiv antigen/antibody, combination assay, screening	<1%	2,077	$33K
73610		<1%	5,813	$33K
86901		<1%	32,734	$33K
84520		<1%	22,627	$33K
80051		<1%	16,187	$32K
77080		<1%	512	$31K
86787		<1%	4,087	$31K
76818		<1%	483	$31K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	39	$31K
84703		<1%	9,595	$31K
95117		<1%	1,535	$31K
11043		<1%	97	$31K
93308		<1%	509	$30K
93454		<1%	25	$30K
85660		<1%	9,683	$30K
86708		<1%	4,220	$29K
73030		<1%	5,430	$29K
86430		<1%	8,084	$29K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	18,754	$29K
72110		<1%	696	$29K
85730		<1%	29,555	$28K
87480		<1%	3,244	$28K
87510		<1%	3,244	$28K
82378		<1%	2,659	$28K
86200		<1%	3,762	$28K
86592		<1%	12,129	$28K
74018		<1%	2,060	$27K
86160		<1%	2,591	$27K
84153		<1%	2,605	$27K
82533		<1%	2,670	$26K
76882		<1%	660	$26K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	247	$26K
87660		<1%	3,077	$25K
83605		<1%	13,472	$25K
86800		<1%	2,648	$25K
99495		<1%	387	$25K
73130		<1%	7,285	$24K
86364		<1%	1,924	$24K
86304		<1%	2,099	$23K
92557		<1%	5,586	$23K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	1,773	$23K
76641		<1%	381	$21K
88112		<1%	903	$20K
72040		<1%	1,719	$20K
86141		<1%	2,743	$20K
73502		<1%	2,381	$20K
73110		<1%	3,533	$20K
86258		<1%	1,302	$20K
84165		<1%	3,237	$20K
76819	Fetal biophysical profile; without non-stress testing	<1%	311	$19K
74019		<1%	1,415	$19K
42830		<1%	12	$19K
85652		<1%	11,513	$19K
72131		<1%	791	$18K
97166		<1%	445	$18K
84156		<1%	9,890	$17K
84134		<1%	1,981	$17K
83525		<1%	2,522	$17K
87046		<1%	1,809	$17K
96127		<1%	4,695	$17K
86665		<1%	1,168	$17K
84154		<1%	2,014	$16K
82951		<1%	2,060	$16K
86146		<1%	468	$16K
77336		<1%	255	$16K
82977		<1%	3,980	$16K
0001A		<1%	440	$16K
93880		<1%	194	$16K
86318		<1%	1,479	$15K
83521		<1%	985	$15K
74174		<1%	163	$15K
99406		<1%	1,114	$15K
90734		<1%	2,261	$15K
29515		<1%	282	$15K
90716		<1%	3,174	$14K
70470		<1%	172	$14K
82024		<1%	578	$13K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	707	$13K
82805		<1%	3,026	$13K
82465		<1%	3,352	$13K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	30,790	$13K
90656		<1%	705	$13K
86580		<1%	1,360	$12K
80055		<1%	778	$12K
90682		<1%	233	$12K
84466		<1%	1,643	$12K
82310		<1%	4,840	$12K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	16	$12K
70487		<1%	171	$11K
92587		<1%	83	$11K
81025		<1%	52,519	$11K
86301		<1%	990	$11K
80197		<1%	1,327	$11K
76820		<1%	3,558	$11K
73080		<1%	1,974	$11K
73590		<1%	3,367	$11K
86765		<1%	1,537	$10K
86231		<1%	1,271	$10K
80164		<1%	1,636	$10K
87205		<1%	5,884	$10K
73700		<1%	300	$10K
0011A		<1%	287	$10K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	36	$9K
82248		<1%	4,729	$9K
83090		<1%	885	$9K
82077		<1%	17,641	$9K
80069		<1%	1,851	$9K
70498		<1%	1,421	$9K
88341		<1%	435	$9K
83721		<1%	2,107	$8K
J0558	Injection, penicillin g benzathine and penicillin g procaine, 100,000 units	<1%	302	$8K
84681		<1%	744	$8K
87045		<1%	1,578	$8K
82247		<1%	3,779	$8K
88304		<1%	2,129	$8K
83921		<1%	695	$8K
87102		<1%	1,817	$8K
84075		<1%	4,229	$8K
91320		<1%	69	$7K
72072		<1%	656	$7K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	137	$7K
86705		<1%	1,222	$7K
82040		<1%	2,994	$7K
85379		<1%	5,150	$7K
0012A		<1%	193	$7K
74178		<1%	37	$7K
73140		<1%	1,097	$7K
74022		<1%	7,545	$7K
74240		<1%	110	$7K
82553		<1%	2,018	$7K
83498		<1%	429	$7K
84478		<1%	46	$7K
85597		<1%	674	$7K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	469	$6K
86255		<1%	971	$6K
80177		<1%	3,729	$6K
90620		<1%	722	$6K
73552		<1%	1,319	$6K
73090		<1%	2,675	$6K
83010		<1%	1,020	$6K
0002A		<1%	161	$6K
73560		<1%	949	$6K
84445		<1%	181	$6K
92511		<1%	78	$6K
86703		<1%	845	$6K
82652		<1%	383	$6K
82330		<1%	841	$6K
90688		<1%	434	$6K
84425		<1%	606	$6K
83655		<1%	1,367	$6K
86735		<1%	791	$5K
92579		<1%	627	$5K
99383		<1%	208	$5K
84155		<1%	2,981	$5K
71101		<1%	536	$5K
0134A		<1%	177	$5K
82140		<1%	1,393	$5K
94010		<1%	312	$5K
85045		<1%	2,987	$5K
88142		<1%	380	$5K
0071A		<1%	135	$5K
86593		<1%	1,961	$5K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	33,124	$5K
82952		<1%	1,990	$5K
72170		<1%	4,705	$5K
90661		<1%	229	$5K
93298		<1%	273	$5K
84112		<1%	1,381	$5K
72050		<1%	105	$5K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	22	$4K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	16,911	$4K
99381		<1%	65	$4K
87209		<1%	441	$4K
0124A		<1%	134	$4K
94799		<1%	965	$4K
99195		<1%	75	$4K
0013A		<1%	104	$4K
94726		<1%	41	$4K
87075		<1%	1,299	$4K
86777		<1%	464	$4K
29125		<1%	1,577	$4K
73060		<1%	1,037	$3K
92588		<1%	32	$3K
83993		<1%	271	$3K
84630		<1%	674	$3K
73221		<1%	24	$3K
72082		<1%	58	$3K
82525		<1%	571	$3K
85613		<1%	497	$3K
86644		<1%	447	$3K
99384		<1%	82	$3K
84132		<1%	2,941	$3K
86694		<1%	522	$3K
97535	Self-care/home management training, each 15 minutes	<1%	650	$3K
85018		<1%	4,806	$3K
86920		<1%	914	$3K
86618		<1%	176	$3K
87449		<1%	510	$3K
73120		<1%	335	$3K
86880		<1%	779	$3K
70360		<1%	173	$3K
86300		<1%	189	$3K
69210		<1%	1,146	$3K
80185		<1%	372	$3K
90480		<1%	73	$3K
85014		<1%	3,246	$3K
81002		<1%	10,686	$3K
72070		<1%	171	$2K
84207		<1%	308	$2K
90621		<1%	46	$2K
86308		<1%	1,364	$2K
88185		<1%	21	$2K
80178		<1%	756	$2K
82677		<1%	217	$2K
89055		<1%	272	$2K
94664		<1%	1,688	$2K
10061		<1%	18	$2K
85044		<1%	1,436	$2K
86812		<1%	139	$2K
86709		<1%	366	$2K
87040		<1%	3,141	$2K
12011		<1%	1,801	$2K
87177		<1%	435	$2K
0003A		<1%	52	$2K
85246		<1%	127	$2K
86039		<1%	275	$2K
85705		<1%	299	$2K
85306		<1%	174	$2K
99382		<1%	25	$2K
85240		<1%	152	$2K
0064A		<1%	51	$2K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	94	$2K
87338		<1%	173	$2K
82088		<1%	116	$2K
86036		<1%	221	$2K
73600		<1%	278	$2K
87428		<1%	92	$2K
83695		<1%	190	$2K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	4,591	$2K
J3480	Injection, potassium chloride, per 2 meq	<1%	3,705	$2K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	4,526	$2K
J2060	Injection, lorazepam, 2 mg	<1%	9,096	$2K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,607	$2K
80202		<1%	104	$2K
92523		<1%	14	$2K
92520		<1%	44	$2K
86336		<1%	217	$1K
86778		<1%	147	$1K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	282	$1K
81374		<1%	30	$1K
12002		<1%	1,666	$1K
85300		<1%	184	$1K
73564		<1%	150	$1K
82962		<1%	3,126	$1K
G0008	Administration of influenza virus vaccine	<1%	326	$1K
85245		<1%	85	$1K
83037		<1%	512	$1K
85670		<1%	328	$1K
94760		<1%	1,640	$1K
82103		<1%	199	$1K
12001		<1%	2,297	$1K
72128		<1%	59	$1K
86335		<1%	67	$1K
73521		<1%	39	$1K
84244		<1%	113	$1K
85732		<1%	244	$1K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	13	$1K
90461		<1%	418	$1K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	14	$994.75
90658		<1%	83	$984.89
73620		<1%	341	$955.49
84300		<1%	488	$939.48
J0690	Injection, cefazolin sodium, 500 mg	<1%	8,989	$918.75
82172		<1%	73	$911.02
84295		<1%	643	$904.55
93270		<1%	55	$902.33
82390		<1%	237	$876.77
73070		<1%	157	$874.20
77072		<1%	15	$870.26
92567		<1%	6,840	$869.55
84305		<1%	116	$865.16
73100		<1%	161	$864.23
93922		<1%	24	$820.57
85303		<1%	82	$786.98
86645		<1%	84	$780.84
82435		<1%	549	$734.64
93296		<1%	52	$727.21
96401		<1%	23	$705.62
85384		<1%	443	$698.30
84166		<1%	65	$676.02
87517		<1%	26	$664.95
88184		<1%	15	$620.79
87324		<1%	131	$601.46
70480		<1%	13	$601.34
0081A		<1%	18	$593.97
91200		<1%	12	$575.93
0072A		<1%	15	$563.27
83930		<1%	351	$556.02
92524		<1%	12	$551.68
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	14	$542.91
97022		<1%	81	$519.28
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	4,737	$510.53
76870		<1%	1,136	$507.43
82668		<1%	72	$490.02
70355		<1%	26	$444.10
86341		<1%	33	$430.10
84145		<1%	403	$422.54
97802		<1%	49	$413.89
82164		<1%	84	$349.20
88173		<1%	67	$335.54
87106		<1%	49	$322.07
92228		<1%	39	$314.55
82679		<1%	31	$303.88
J1756	Injection, iron sucrose, 1 mg	<1%	3,322	$294.36
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	3,632	$267.06
82671		<1%	12	$261.12
90744		<1%	212	$238.30
90473		<1%	77	$237.60
69200		<1%	186	$220.99
73000		<1%	26	$217.17
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	942	$210.91
83718		<1%	39	$198.96
85049		<1%	79	$179.46
82626		<1%	14	$178.15
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	52	$177.03
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	19,538	$172.90
96376		<1%	4,577	$167.02
97035		<1%	29	$163.04
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	15,020	$153.71
83835		<1%	12	$150.84
69209		<1%	82	$150.81
80156		<1%	26	$149.70
73660		<1%	13	$144.42
82239		<1%	42	$142.37
87280		<1%	17	$131.68
82232		<1%	15	$131.23
86256		<1%	14	$128.92
J2359	Injection, olanzapine, 0.5 mg	<1%	16	$126.48
86664		<1%	12	$120.53
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,442	$120.00
87076		<1%	44	$108.94
J7030	Infusion, normal saline solution , 1000 cc	<1%	58,906	$107.86
93320		<1%	860	$106.00
84590		<1%	14	$105.60
86663		<1%	12	$103.50
86015		<1%	13	$103.37
J8540	Dexamethasone, oral, 0.25 mg	<1%	10,225	$96.16
99214	Doctor's office visit, returning patient (more involved)	<1%	60	$82.01
93325		<1%	2,418	$80.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	20,353	$79.43
83935		<1%	26	$79.35
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,436	$65.34
51701		<1%	13	$64.79
90474		<1%	21	$63.30
80179		<1%	1,228	$61.83
77073		<1%	27	$59.64
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	850	$56.79
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	11,914	$56.25
80175		<1%	12	$55.17
80143		<1%	1,344	$54.96
90680		<1%	8,183	$53.06
82374		<1%	14	$49.80
90672		<1%	72	$48.64
96377		<1%	15	$47.60
90697		<1%	1,349	$46.06
99213	Doctor's office visit, returning patient (routine)	<1%	63	$38.77
82375		<1%	42	$37.85
90723		<1%	9,105	$37.50
80305		<1%	325	$35.01
J1650	Injection, enoxaparin sodium, 10 mg	<1%	9,309	$34.69
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	561	$31.58
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	3,643	$30.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	754	$27.00
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	558	$25.05
J2270	Injection, morphine sulfate, up to 10 mg	<1%	18,757	$24.20
J7050	Infusion, normal saline solution, 250 cc	<1%	6,356	$19.23
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	368	$16.98
J2401	Injection, chloroprocaine hydrochloride, per 1 mg	<1%	14	$14.76
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	460	$13.12
J7120	Ringers lactate infusion, up to 1000 cc	<1%	21,914	$12.01
85347		<1%	604	$11.94
90647		<1%	9,178	$7.00
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	14,022	$6.83
81000		<1%	36	$6.48
96368		<1%	1,676	$6.13
J1836	Injection, metronidazole, 10 mg	<1%	174	$6.12
87015		<1%	15	$4.51
87206		<1%	15	$3.65
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	168	$3.23
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,288	$3.00
J2704	Injection, propofol, 10 mg	<1%	12,983	$2.42
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	16,623	$1.28
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	4,311	$0.93
36416		<1%	834	$0.06
J1644	Injection, heparin sodium, per 1000 units	<1%	6,829	$0.04
J1630	Injection, haloperidol, up to 5 mg	0%	4,562	$0.00
90696		0%	2,387	$0.00
J3490	Unclassified drugs	0%	2,094	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	2,323	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	1,317	$0.00
J0500	Injection, dicyclomine hcl, up to 20 mg	0%	180	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	569	$0.00
C1769	Guide wire	0%	2,625	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	289	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	144	$0.00
J1815	Injection, insulin, per 5 units	0%	5,631	$0.00
11045		0%	286	$0.00
76377		0%	1,381	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	1,506	$0.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	0%	518	$0.00
J9045	Injection, carboplatin, 50 mg	0%	1,139	$0.00
J0461	Injection, atropine sulfate, 0.01 mg	0%	684	$0.00
99292		0%	88	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	668	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	806	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	561	$0.00
J7042	5% dextrose/normal saline (500 ml = 1 unit)	0%	720	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	64	$0.00
91301		0%	653	$0.00
90632		0%	385	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	357	$0.00
90619		0%	37	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	38	$0.00
A4648	Tissue marker, implantable, any type, each	0%	176	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	46	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	65	$0.00
91307		0%	251	$0.00
A6022	Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each	0%	18	$0.00
91305		0%	26	$0.00
94660		0%	110	$0.00
12013		0%	54	$0.00
90381		0%	192	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	459	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	60	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	397	$0.00
90698		0%	31	$0.00
83520		0%	32	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	12	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	65	$0.00
J1165	Injection, phenytoin sodium, per 50 mg	0%	85	$0.00
94761		0%	1,814	$0.00
85362		0%	73	$0.00
95024		0%	13	$0.00
0399T		0%	14	$0.00
91306		0%	25	$0.00
C1753	Catheter, intravascular ultrasound	0%	37	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	13	$0.00
30901		0%	12	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	41	$0.00
J0456	Injection, azithromycin, 500 mg	0%	22	$0.00
C1781	Mesh (implantable)	0%	15	$0.00
90710		0%	2,344	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	1,806	$0.00
J2310	Injection, naloxone hydrochloride, per 1 mg	0%	1,343	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	1,859	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	2,439	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	914	$0.00
90700		0%	3,021	$0.00
90633		0%	6,547	$0.00
93321		0%	438	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	1,524	$0.00
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	0%	910	$0.00
90707		0%	3,569	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	1,733	$0.00
76942		0%	261	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	1,428	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	1,434	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	1,609	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	2,370	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	820	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	869	$0.00
31720		0%	18	$0.00
J1050	Injection, medroxyprogesterone acetate, 1 mg	0%	2,719	$0.00
G9622	Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method	0%	1,093	$0.00
J2400	Injection, chloroprocaine hydrochloride, per 30 ml	0%	201	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	38	$0.00
90380		0%	90	$0.00
J9060	Injection, cisplatin, powder or solution, 10 mg	0%	115	$0.00
A4315	Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone	0%	162	$0.00
J1245	Injection, dipyridamole, per 10 mg	0%	139	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	617	$0.00
91313		0%	178	$0.00
85060		0%	44	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	101	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	887	$0.00
0042T		0%	94	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	165	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	64	$0.00
91300		0%	706	$0.00
94729		0%	24	$0.00
91308		0%	106	$0.00
J3250	Injection, trimethobenzamide hcl, up to 200 mg	0%	14	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	238	$0.00
91312		0%	131	$0.00
82731		0%	16	$0.00
99152		0%	38	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	52	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	260	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	293	$0.00
16020		0%	17	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	14	$0.00
92978		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAMSCHRODER, ROBIN (PRESIDENT, VAL BASED ENT & CFO)

Same official

Other billing entities under DAMSCHRODER, ROBIN

Full network →

Provider	Location	Paid
Henry Ford Health System	Detroit, MI	$334.91M
Henry Ford Health Providence Hospital	Novi, MI	$72.76M
Henry Ford Wyandotte Hospital	Wyandotte, MI	$60.54M
Henry Ford Health Macomb Oakland Hospital	Warren, MI	$59.25M
W.A. Foote Memorial Hospital	Jackson, MI	$41.32M
Henry Ford Macomb Hospital Corporation	Clinton Twp, MI	$40.96M
Henry Ford Health Genesys Hospital	Grand Blanc, MI	$31.39M
Henry Ford Health Macomb Oakland Hospital	Madison Heights, MI	$24.76M
Henry Ford Health System	West Bloomfield, MI	$19.27M
Henry Ford Health Rochester Hospital	Rochester, MI	$11.98M
Henry Ford Health River District Hospital	East China, MI	$4.59M
W.A. Foote Memorial Hospital	Jackson, MI	$2.11M
Henry Ford Health Providence Hospital	Novi, MI	$255K
Henry Ford Health ST. John Hospital	Detroit, MI	$4K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.